Keywords: Insulin; Obesity; Metabolic syndrome; Salivary gland function; Mitochondria; DPP-IV inhibitor; Vildagliptin;
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: Vildagliptin; Drug-induced liver injury; Hypersensitivity; Covalent binding; Nucleophilic trapping agents; ALG; alogliptin; ANG; anagliptin; CRP; C-reactive protein; CYP; cytochrome P450; DILI; drug-induced liver injury; DLST; drug-induced lymphocyte stim
Keywords: Dipeptidyl peptidase-4 inhibitors; Glycated hemoglobin; Hemoglobin glycation index; Type 2 diabetes; Vildagliptin;
Keywords: High-fat diet; Metformin; Streptozotocin; Type 2 diabetes mellitus; Vildagliptin;
Keywords: Vildagliptin; Insulin; Type 2 diabetes mellitus; HbA1c; Hypoglycemia;
Keywords: Vildagliptin; Impurity degradation; Identification; Isolation; LC/ESI–MSn; NMR
Keywords: Type 2 diabetes mellitus; Vildagliptin; Sitagliptin; Fasting plasma glucose; Dipeptidyl peptidase inhibitors
Keywords: Cyclosporine; Nephrotoxicity; Vildagliptin; Inflammation and apoptosis
Keywords: Vildagliptin; Sulfonylurea; Clinical trial; Hypoglycemia;
Keywords: Vildagliptin; Saxagliptin; Experimental design; Dansylation; Charge transfer reaction; Hantzsch reaction
Keywords: Metformin; Vildagliptin; Derivative; Derivative ratio; Ratio subtraction; Mean centering
Dipeptidyl peptidase IV (DPP-IV) inhibition prevents fibrosis in adipose tissue of obese mice
Keywords: Obesity; Fibrosis; Extracellular matrix; Dipeptidyl peptidase IV inhibitor; Vildagliptin; Neuropeptide Y;
Dipeptidyl Peptidase-4 Inhibitor, Vildagliptin, Improves Trabecular Bone Mineral Density and Microstructure in Obese, Insulin-Resistant, Pre-diabetic Rats
Keywords: bone density; bone histomorphometry; insulin resistance; obesity; vildagliptin; densité osseuse; histomorphométrie osseuse; insulinorésistance; obésité; vildagliptine;
SGLT2-inhibitor and DPP-4 inhibitor improve brain function via attenuating mitochondrial dysfunction, insulin resistance, inflammation, and apoptosis in HFD-induced obese rats
Keywords: Obese-insulin resistance; Cognitive function; Mitochondrial function; Synaptic plasticity; Dapagliflozin; Vildagliptin; HFD; high fat diet; GLP1; glucagon-like peptide 1; OFT; open field test; OGTT; oral glucose tolerance test; MWM; Morris water maze; HDL
Efetividade e segurança de vildagliptina comparativamente com outros antidiabéticos orais em doentes com diabetes tipo 2: estudo EDGE em Portugal
Keywords: Diabetes mellitus tipo 2; Vildagliptina; ObservacionalType 2 diabetes mellitus; Vildagliptin; Observational
Effectiveness of vildagliptin versus other oral antidiabetes drugs as add-on to sulphonylurea monotherapy: Post hoc analysis from the EDGE study
Keywords: Real-life setting; India; Vildagliptin; Sulphonylurea;
Patient engagement impacts glycemic management with vildagliptin and vildagliptin/metformin (single pill) regimens in type 2 diabetes mellitus (the GLORIOUS study)
Keywords: Type 2 diabetes mellitus; Diabetes mellitus; Vildagliptin; Dipeptidyl peptidase-4 inhibitor; Outcomes; Effectiveness;
Dipeptidyl peptidase-4 inhibitor, vildagliptin, inhibits pancreatic beta cell apoptosis in association with its effects suppressing endoplasmic reticulum stress in db/db mice
Keywords: ER; endoplasmic reticulum; TRIB3; tribbles homolog 3; ATF-4; activating transcription factor 4; CHOP; C/EBP homologous protein; GLP-1; Glucagon-like peptide-1; Endoplasmic reticulum; Type 2 diabetes; Vildagliptin;
DPP-4 Inhibitor and PPARγ Agonist Restore the Loss of CA1 Dendritic Spines in Obese Insulin-resistant Rats
Keywords: Vildagliptin; Pioglitazone; Dendritic spines; High-fat diet; Insulin resistance;
Human Nitrilase-like Protein Does Not Catalyze the Hydrolysis of Vildagliptin
Keywords: vildagliptin; M20.7; LAY151; nitrilase; NIT1; NIT2; hydrolysis
Analgesic and anti-inflammatory effectiveness of sitagliptin and vildagliptin in mice
Keywords: Arthritis; Mechanical and thermal touch sensitivity; Mice; Mustard oil; Sitagliptin; Vildagliptin
Vildagliptine versus sitagliptine en addition à la metformine : sont-elles équivalentes ? Résultats de l'étude OPTIMA
Keywords: Diabète de type 2; vildagliptine; sitagliptine; enregistrement glycémique continu; profils glycémiques circadiens; Type 2 diabetes mellitus; vildagliptin; sitagliptin; continuous glucose monitoring; circadian glycemic profiles;
Simultaneous determination of metformin and vildagliptin in human plasma by a HILIC–MS/MS method
Keywords: Metformin; Vildagliptin; LC–MS/MS; Human plasma; HILIC
RP-HPLC determination of vildagliptin in pure and in tablet formulation
Keywords: Vildagliptin; RP-HPLC; Tablets;
Vildagliptin more effectively achieves a composite endpoint of HbA1c < 7.0% without hypoglycaemia and weight gain compared with glimepiride after 2 years of treatment
Keywords: Type 2 diabetes (T2D); Incretin-based therapy; Dipeptidyl peptidase-4 (DPP-4) inhibitors; Vildagliptin; Composite endpoint
Spectrophotometric and spectrofluorimetric methods for the determination of saxagliptin and vildagliptin in bulk and pharmaceutical preparations
Keywords: Saxagliptin; Vildagliptin; 1,2-Naphthoquinone-4-sulfonic acid sodium salt; 4-Chloro-7-nitrobenzofurazan; Spectrophotometry; Spectrofluorimetry
Relationships between the islets blood flow, nitric oxide, insulin, and cytosolic calcium in rat pancreatic islets: Effects of DPP-IV inhibitor vildagliptin
Keywords: Diabetic rats; Vildagliptin; Islets blood flow; Insulin; Nitric oxide; Cytosolic calcium
Method comparison of dipeptidyl peptidase IV activity assays and their application in biological samples containing reversible inhibitors
Keywords: DPP; dipeptidyl peptidase; ADA; adenosine deaminase; Gly-Pro-4-Me-β-NA; glycyl-prolyl-4-methoxy-β-naphthylamide; Gly-Pro-AMC; glycyl-prolyl-7-amino-4-methylcoumarin; Gly-Pro-pNA; glycyl-prolyl-para-nitroanilide; CD26; DPP4; DPPIV inhibitors; Method vali
Continuous glucose profiles with vildagliptin versus sitagliptin in add-on to metformin: Results from the randomized Optima study
Keywords: Type 2 diabetes mellitus; Vildagliptin; Sitagliptin; Continuous glucose monitoring; Circadian glycaemic profilesDiabète de type 2; Vildagliptine; Sitagliptine; Enregistrement glycémique continu; Profils glycémiques circadiens
DPP-4 inhibitors in the management of type 2 diabetes: A critical review of head-to-head trials
Keywords: Clinical trial-DPP-4 inhibitor; Alogliptin; Linagliptin; Saxagliptin; Sitagliptin; Vildagliptin; Type 2 diabetes mellitus; ReviewDiabète de type 2; Essai clinique; Inhibiteur de la DPP-4; Alogliptine; Linagliptine; Saxagliptine; Sitagliptine; Vildagliptin
The dipeptidyl peptidase IV (CD26, EC 3.4.14.5) inhibitor vildagliptin is a potent antihyperalgesic in rats by promoting endomorphin-2 generation in the spinal cord
Keywords: Vildagliptin; Antihyperalgesic effect; Dipeptidyl peptidase IV; Endomorphin-2 generation; Carrageenan-induced hyperalgesia
The DPP-4 inhibitor vildagliptin increases pancreatic beta cell mass in neonatal rats
Keywords: DPP-4; Vildagliptin; Beta cell mass; Apoptosis; Replication; Glucagon-like peptide-1; Pancreatic insulin content
GLP-1 for type 2 diabetes
Keywords: GLP-1; DPP-4 inhibition; Type 2 diabetes; Exenatide; Liraglutide; Albiglutide; Taspoglutide; Lixisenatide; Sitagliptin; Vildagliptin; Saxagliptin; Alogliptin; Linagliptin
An analysis of the impact of FDA's guidelines for addressing cardiovascular risk of drugs for type 2 diabetes on clinical development
Keywords: Exenatide; Sitagliptin; Saxagliptin and liraglutide; Vildagliptin; Insulin inhalation powder; Alogliptin
Tolerability of Dipeptidyl Peptidase-4 Inhibitors: A Review
Keywords: alogliptin; dipeptidyl peptidase-4 (DPP-4) inhibitor; linagliptin; saxagliptin; sitagliptin; vildagliptin
Clinical Pharmacology of Incretin Therapies for Type 2 Diabetes Mellitus: Implications for Treatment
Keywords: alogliptin; DPP-4 inhibitors; exenatide; GLP-1 receptor agonists; incretin therapies; liraglutide; saxagliptin; sitagliptin; type 2 diabetes; vildagliptin;
Efficacy and tolerability of vildagliptin as an add-on to glimepiride in Japanese patients with Type 2 diabetes mellitus
Keywords: Dipeptidyl peptidase-4; Glimepiride; HbA1c; Vildagliptin
Liraglutide, but not vildagliptin, restores normoglycaemia and insulin content in the animal model of type 2 diabetes, Psammomys obesus
Keywords: GLP-1; Pancreas; Insulin; Liraglutide; Vildagliptin; Psammomys obesus; Diabetes
Safety and tolerability of vildagliptin vs. thiazolidinedione as add-on to metformin in type 2 diabetic patients with and without mild renal impairment: A retrospective analysis of the GALIANT study
Keywords: Mild renal impairment; Safety; Thiazolidinediones; Vildagliptin
Treatment of elderly patients with type 2 diabetes mellitus: A systematic review of the benefits and risks of dipeptidyl peptidase-4 inhibitors
Keywords: alogliptin; cardiovascular; hypoglycemia; obesity; saxagliptin; sitagliptin; vildagliptin;
Unraveling the Science of Incretin Biology ✩
Keywords: GLP-1 receptor agonist; DPP-4 inhibitor; liraglutide; exenatide; sitagliptin; vildagliptin
Unraveling the Science of Incretin Biology
Keywords: GLP-1 receptor agonist; DPP-4 inhibitor; liraglutide; exenatide; sitagliptin; vildagliptin
Vildagliptin dose-dependently improves glycemic control in Japanese patients with type 2 diabetes mellitus
Keywords: HbA1c; Japanese; Type 2 diabetes mellitus; Vildagliptin
Clinical Application of Incretin-Based Therapy: Therapeutic Potential, Patient Selection and Clinical Use ✩
Keywords: GLP-1 receptor agonist; DPP-4 inhibitor; liraglutide; exenatide; sitagliptin; vildagliptin
Clinical results of treating type 2 diabetic patients with sitagliptin, vildagliptin or saxagliptin – diabetes control and potential adverse events
Keywords: glucagon-like peptide-1; dipeptidyl peptidase-4; type 2 diabetes; sitagliptin; vildagliptin; treatment
Clinical Application of Incretin-Based Therapy: Therapeutic Potential, Patient Selection and Clinical Use
Keywords: GLP-1 receptor agonist; DPP-4 inhibitor; liraglutide; exenatide; sitagliptin; vildagliptin
Dipeptidyl Peptidase-4 as a New Target of Action for Type 2 Diabetes Mellitus: A Systematic Review
Keywords: Dipeptidyl peptidase-4 inhibitor; DPP-4 inhibitors; Sitagliptin; Vildagliptin; Diabetes type 2; Glycohemoglobin A1c; Incretins
DPP-4 inhibition improves glucose tolerance and increases insulin and GLP-1 responses to gastric glucose in association with normalized islet topography in mice with β-cell-specific overexpression of human islet amyloid polypeptide
Keywords: DPP-4; Insulin secretion; Glucose tolerance; Islet amyloid polypeptide; Mice; Vildagliptin
DPP-4 inhibitors
Keywords: glucagon-like peptide-1; dipeptidyl peptidase 4; type-2 diabetes; sitagliptin; vildagliptin; treatment
GLP-1 based therapy for type 2 diabetes
Keywords: Type 2 diabetes; GLP-1; DPP-IV; Exenatide; Vildagliptin;